You are looking for

Antimicrobial resistance (AMR) is now on the political agenda like never before. The WHO has called AMR a ‘silent pandemic’. The issue has been discussed by the G7 and it is among the priorities highlighted in the mission letter sent by European Commission President Ursula von der Leyen to the Commissioner responsible for health, Stella […]

As Europe enters the fourth wave of COVID-19 and countries start to impose lockdown restrictions, we must not forget that we have the tools to tackle this. European society has undergone a profound transformation since the start of the COVID-19 pandemic. Testing has been placed at the heart of our health systems as one of the […]

The recent pandemic has bluntly exposed some of the gaps in our healthcare systems across Europe and one thing stuck with me the most: we were not prepared. In many ways, we can think of this as a test run of how the world responds to large-scale healthcare crises. There are more complex threats ahead, […]

What key health questions should EU Research & Innovation (R&I) funding aim to address? The Horizon Europe (2021-2027) Health Cluster has provided an answer – well, six answers – which will shape R&I for most of the coming decade. This will also drive my own work in leading the R&I Partnership Policy of MedTech Europe. […]

As we mark World Antibiotic Awareness Week and European Antibiotic Awareness Day, it is vital that we do all we can to address antimicrobial resistance. The medtech sector supports a wide range of tools that reduce infection risk and support antimicrobial stewardship – some are technologically sophisticated; others are startlingly simple. Checklists are just one […]

This blog is part of the Early Diagnosis campaign #BeFirstEarly diagnosis and care can prevent illness from developing and slow disease progression. Lab tests, genetic tests, tests for chronic diseases and modern lab diagnostics can help facilitate earlier intervention and improves outcomes for patients and are increasingly valuable in informing treatment choice. Read the other blogs here: A […]

International efforts to tackle the hepatitis pandemic have reached new heights, especially in the past year since the 69th World Health Assembly (WHA) endorsed the Global Health Sector Strategy (GHSS) on viral hepatitis 2016–2021. It is estimated that some 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus […]

Medtech in the limelight during June’s ‘MedTech Week’ This June, we took one week to debate with our partners across Europe the value of medical technologies to patients, healthcare systems and society at large. For the third year running, member companies and national associations came together to demonstrate the value of medtech in our day-to-day […]

The world’s highest health policy-setting body, World Health Assembly (WHA), is set to hold its 70th annual meeting in Geneva from 22-31 May 2017. It is here that health ministers from the World Health Organization’s (WHO’s) 194 member states will review the WHO’s work, set new goals and assign new tasks. Delegates at #WHA70 are […]